Evidence map›Paper›PMID 39732675›Full record

Observational studyBMC geriatrics2024

Effectiveness and cost-effectiveness of a single home-based fall prevention program: a prospective observational study based on questionnaires and claims data.

Karin Niedermann, André Meichtry, Barbara Zindel, Markus J Ernst, Valérie Krafft, Renato Mattli, Irina Nast, Simon Wieser, Markus Wirz, Beatrice Brunner

Abstract readObservational Study
In one paragraph

Observational study in BMC geriatrics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Karin NiedermannZHAW Zurich University of Applied Sciences, School of Health Sciences, Katharina-Sulzer-Platz 9, Winterthur, 8401, Switzerland. karin.niedermann@zhaw.ch.
André MeichtryZHAW Zurich University of Applied Sciences, School of Health Sciences, Katharina-Sulzer-Platz 9, Winterthur, 8401, Switzerland.
Barbara ZindelSwiss League Against Rheumatism, Zurich, Switzerland.
Markus J ErnstZHAW Zurich University of Applied Sciences, School of Health Sciences, Katharina-Sulzer-Platz 9, Winterthur, 8401, Switzerland.
Valérie KrafftSwiss League Against Rheumatism, Zurich, Switzerland.
Renato MattliBFH Bern University of Applied Sciences, School of Health Professions, Bern, Switzerland.
Irina NastZHAW Zurich University of Applied Sciences, School of Health Sciences, Katharina-Sulzer-Platz 9, Winterthur, 8401, Switzerland.
Simon WieserZHAW Zurich University of Applied Sciences, Winterthur Institute of Health Economics, Winterthur, Switzerland.
Markus WirzZHAW Zurich University of Applied Sciences, School of Health Sciences, Katharina-Sulzer-Platz 9, Winterthur, 8401, Switzerland.
Beatrice BrunnerZHAW Zurich University of Applied Sciences, Winterthur Institute of Health Economics, Winterthur, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFall prevention programmes are essential interventions in societies with aging populations. This study assessed the fall rate and other health outcomes, as well as the cost-effectiveness of a home-based fall prevention programme for community-dwelling older people. In a single home visit, trained physical or occupational therapists performed fall risk assessments, eliminated environmental risk factors, and provided tailored exercises.

methodsA prospective, longitudinal observational study was performed with participants of a fall prevention programme who agreed to be followed-up over one year. Baseline data included self-reported falls one month and one year before the intervention. Participants were monitored through bi-monthly telephone calls, assessing their number of falls, fear of falling (using the Falls Efficacy Scale-International (FES-I), quality of life (using the EuroQuol-5 Dimensions-5 Levels, EQ-5D-5L), and physical activity (in minutes per week). Statistical analysis of the data used a Generalized Estimating Equations (GEE) Poisson-Modell for number of falls and a Linear Mixed Model (LMM) for fear of falling, quality of life and physical activity. In addition, health insurance claims data were used to compare the number of medically treated falls in the year before and after the intervention, as well as the related healthcare spending. Cost-effectiveness of the programme versus usual care was estimated as cost per prevented medically treated fall.

resultsOverall, 639 person-years of observation time were analyzed. Participants had a mean age of 81.8 years (+/- 5.2) and 59% were female. On average, the fall rate decreased from 1.35 to 1.02 per person-year, or -23.9% (95%CI from -35.92 to -9.67), fear of falling decreased by -1.27 points (95%CI from -1.50 to -1.05), quality of life improved by -0.88 points (95%CI from -1.09 to -0.68), and physical activity increased by 9.87 min per day (95%CI from 5.65 to 14.09). Analysis of claims data showed a 48.0% reduction (95%CI from 30.5% to 61.0%) in medically treated falls. The average cost per prevented medically treated fall was estimated at approximately 1,353 USD, with a 50% probability of the intervention being cost saving.

conclusionsThis fall prevention programme with a single home visit was found to be effective and cost effective. Health policies should establish such a model as a reimbursed standard care to assist in combatting the increasing burden of falls on individuals and societies.

Indexed as

Accidental FallsCost-Benefit AnalysisAgedAged, 80 and overFemaleFollow-Up StudiesHome Care ServicesHumansLongitudinal StudiesMaleProspective StudiesQuality of LifeSurveys and QuestionnairesCostCost-effectivenessEffectivenessFallsPrevention

Identifiers

PMID39732675
PMCPMC11681629

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.